Warsaw, Poland

Wojciech Luniewski

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Instytut Farmaceutyczny. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wojciech Luniewski. Retrieved from https://idiyas.com/inventor/wojciech-luniewski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wojciech Luniewski: Innovator in Pharmaceutical Processes

Introduction

Wojciech Luniewski is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of imatinib base. His innovative approach has streamlined the process, making it more efficient and accessible.

Latest Patents

Wojciech Luniewski holds a patent for a process for the preparation of imatinib base. This improved method involves several steps, including the reaction of 2-methyl-5-nitroaniline with cyanamide and the subsequent conversion of intermediates to obtain the final product. The process allows for the use of simple starting materials while avoiding laborious isolation and purification steps, facilitating scale-up.

Career Highlights

Luniewski is associated with the Instytut Farmaceutyczny, where he has been instrumental in advancing pharmaceutical research. His work has not only contributed to the development of imatinib but has also paved the way for further innovations in drug formulation.

Collaborations

He has collaborated with notable colleagues, including Wojciech Szczepek and Maciej Skarzynski. These partnerships have enhanced the research environment and fostered innovation within the institution.

Conclusion

Wojciech Luniewski's contributions to pharmaceutical processes exemplify the impact of innovative thinking in drug development. His work continues to influence the field and improve the efficiency of pharmaceutical manufacturing.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…